OTC · CIMVF
Pideka Group Inc.
$0.01$0.00 (0.0%)
Pideka Group Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
Loading market information…
OTC · PARNF · USD
Stock price, earnings
Quote as of Apr 22, 2025, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Parnell Pharmaceuticals Holdings Ltd’s quoted price sits in the lower half of its reported 52-week range, 77.14% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Parnell Pharmaceuticals Holdings Ltd’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Parnell Pharmaceuticals Holdings Ltd is a well-established biopharmaceutical company that focuses on the entire lifecycle of animal health solutions, from development and manufacturing to global distribution. The company organizes its operations into four distinct business units: Companion Animal, Production Animal - U.S., Production Animal - Rest of World, and Manufacturing Operations. Its diverse product portfolio includes key offerings like estroPLAN and GONAbreed, which are hormone-based treatments designed to enhance reproductive performance in cattle. For addressing osteoarthritis, Parnell provides Zydax, a therapeutic injection for dogs and horses, as well as Glyde, a nutraceutical supplement. The company further offers Parnell PROcept, a protocol that incorporates an additional estroPLAN injection. Beyond pharmaceutical products, Parnell also developed mySYNCH, a digital platform crafted to assist veterinarians and livestock producers in streamlining reproduction management and improving economic yields. Parnell Pharmaceuticals Holdings Ltd was founded in 2009 and maintains its corporate headquarters in Alexandria, Australia.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 03:29 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| -$0.11 |
| $11.78M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.01$0.00 (0.0%)
Pideka Group Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.04-$0.00 (-2.67%)
CBD Global Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 65.37% below the high.
$0.00-$0.00 (-85.71%)
RCMW Group, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Kallo Inc.: Healthcare · Medical - Healthcare Information Services.
$0.01+$0.01 (+166.67%)
Silo Wellness Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.50+$0.17 (+51.52%)
Irwin Naturals Inc.’s quoted price sits in the lower half of its reported 52-week range, 53.27% below the high.
$0.00-$0.00 (-15.56%)
AusCann Group Holdings Ltd: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.02+$0.00 (+16.18%)
Can B Corp.’s quoted price sits in the lower half of its reported 52-week range, 89.55% below the high.
